App-Based diet tracking tested in rare disease

NCT ID NCT05738005

Recruiting now Knowledge-focused Sponsor: Barbara Ann Karmanos Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot trial is testing whether amyloidosis patients can use the MyFitnessPal smartphone app to track their daily food and supplement intake for 8 weeks. The goal is to see if this low-cost method is feasible for studying malnutrition and weight loss in this condition. Forty adults with any type of amyloidosis will use the app and complete questionnaires to measure how well they stick with the tracking.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MyFitnessPal smartphone application
What this could lead to: If successful, this could show that a simple smartphone app is a feasible way to collect detailed dietary data in amyloidosis patients, helping researchers better understand malnutrition in this disease.
What could go wrong: This is a very small pilot study (40 people) testing only whether patients will use the app, not whether it improves health. The results may not apply to all amyloidosis patients, and the app may not capture accurate dietary information.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyloidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMYLOIDOSIS

Contacts and locations

Locations

Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.